# A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC

Source: https://onco.cc/trials/nct05879068/  
OnCo record `nct05879068` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of PM8002 in small-cell lung cancer, run by Biotheus Inc., active and no longer recruiting.

## Summary

A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC is a phase 2 interventional study registered as NCT05879068 by Biotheus Inc., with 99 participants enrolled, started 2022-05-27 and due to reach its primary completion in 2025-04-30. Interventions recorded: PM8002 and Paclitaxel.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05879068
- Phase: 2
- Setting: A Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of PM8002 Injection in Combination With Paclitaxel Injection as Second Line Treatment for Small Cell Lung Cancer(SCLC)
- Sponsor: Biotheus Inc.
- Enrolled: 99

## Sources

- ClinicalTrials.gov NCT05879068: https://clinicaltrials.gov/study/NCT05879068

## Connected records

- cancers: [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [PM8002](https://onco.cc/drugs/pm8002/)
- companies: [BioNTech](https://onco.cc/companies/biontech/)

---
JSON: https://onco.cc/api/v1/entities/nct05879068.json